Thursday, October 22, 2026Live markets
Advertise Contact
BBTC$81,175.01 -4.05%EETH$2,379.23 -4.43%BBNB$729.25 -2.64%XXRP$1.30 -6.17%SSOL$103.20 -4.43%TTRX$0.3277 -0.99%ZZEC$1,209.55 -10.01%HHYPE$77.25 -4.89%DDOGE$0.0782 -5.63%XXMR$597.21 -3.21%LLINK$11.89 -6.11%AADA$0.2108 -7.63%NNEAR$4.87 -7.69%XXLM$0.1749 -5.59%
Advertise
ExchangesSource: Blockonomi ·

Roche Holding AG (RHHBY) Stock: Rises After Strong Q3 Sales and Major FDA Approvals

Roche stock rises 1.18% as third-quarter sales climb 7% at constant exchange rates. Roche reports CHF 46.5 billion in nine-month sales, fueled by key medicines. FDA approvals for Tecentriq and Enspryng expand Roche’s treatment portfolio.

Summary from Blockonomi

Read the full story on Blockonomi →

This headline and summary were published by Blockonomi. CryptoNewsroom did not write or verify this story and shows it only as a pointer to the original. See how we select sources. Nothing here is financial advice.

From our newsroom

All →

More Exchanges headlines

All →